<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0204870.ref032">
 <label>32</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Dong</surname>
   <given-names>Y</given-names>
  </name>, 
  <name>
   <surname>Sun</surname>
   <given-names>Q</given-names>
  </name>, 
  <name>
   <surname>Zhang</surname>
   <given-names>X</given-names>
  </name>. 
  <article-title>PD-1 and its ligands are important immune checkpoints in cancer</article-title>. 
  <source>Oncotarget</source>. 
  <year>2017</year>;
  <volume>8</volume>(
  <issue>2</issue>):
  <fpage>2171</fpage>â€“
  <lpage>86</lpage>. 
  <comment>doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.13895" xmlns:xlink="http://www.w3.org/1999/xlink">10.18632/oncotarget.13895</ext-link>
  </comment> ; PubMed Central PMCID: PMCPMC5356790.
  <?supplied-pmid 27974689?>
  <pub-id pub-id-type="pmid">27974689</pub-id>
 </mixed-citation>
</ref>
